[What is mastopathy at risk? Epidemiologic and clinical basis].
One out of 11 women is destined to develop breast cancer. All women should be "under observation". Does a "normal" breast really exist? A discharge from a single orifice could suggest a papillomatosis, a real borderline lesion, the adenofibroma practically never degenerates, the essential problem is that of the fibrocystic disease, (or mastosis) which was the object of a recent detailed analysis (W. Dupont and D. Page), pre-menstrual mastodynia does not seem to be a risk factor. On the other hand, certain dystrophic lesions constitute a high risk, such as atypical epithelial hyperplasia, especially if it is associated with a direct family history of breast cancer. Recent studies on mammary cysts insist on their hormone and electrolyte content, the presence of EGF, as well as that of certain proteins (GCDFP 15). They also insist on the local tissue enzymatic activities, the importance of myoepithelial cells and of fibroblasts. On a practical level, the attention is drawn on: cysts whose diameter exceeds 5 mm, certain histological lesions found during the biopsies. The value of mammography and thermography in the assessment of the high risk is discussed. Finally, the present well-established notions are recalled: the family history, late pregnancies, the diet, the weight, certain pathological associations, the endogenous hormonal balance bearing on E2/P and the blood prolactin level, the exogenous hormone intake.
Gorins
A
A
Centre des Maladies du Sein, Hôpital Saint Louis, Paris.
Kottler
M L
ML
D001943:Breast Neoplasms / Q000453:epidemiology / Q000209:etiology; D005260:Female; D006801:Humans; D011230:Precancerous Conditions / Q000453:epidemiology / Q000209:etiology; D012307:Risk Factors
Qu'est-ce qu'une mastopathie à risque? Bases épidémiologiques et cliniques.